| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2009 | US20090208953 Neurofibromin pathway modulators |
| 08/20/2009 | US20090208939 Identification of Molecular Diagnostic Markers for Endometriosis in Blood Lymphocytes |
| 08/20/2009 | US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition |
| 08/20/2009 | US20090208591 Gallium compositions for the treatment of liver cancer and methods of use |
| 08/20/2009 | US20090208590 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 08/20/2009 | US20090208589 Novel hydrophilic polymers as medical lubricants and gels |
| 08/20/2009 | US20090208584 Solid preparation |
| 08/20/2009 | US20090208583 Tablets comprising candesartan cilexetil |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208580 Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| 08/20/2009 | US20090208579 Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| 08/20/2009 | US20090208575 Pharmaceutical Composition Of Acid Labile Substances |
| 08/20/2009 | US20090208573 Novel polymorph form of irbesartan |
| 08/20/2009 | US20090208571 Dosage form containing pantoprazole as active ingredient |
| 08/20/2009 | US20090208570 Extended Release Dosage forms of Metoprolol |
| 08/20/2009 | US20090208564 Compositions of asymmetric interfering RNA and uses thereof |
| 08/20/2009 | US20090208563 Method for delivering genes |
| 08/20/2009 | US20090208558 Use of Combination Preparations Comprising Antifungal Agents |
| 08/20/2009 | US20090208557 ocular implant comprising a tyrosine kinase inhibitor and a polymer matrix; 2,5-dimethyl-2H-pyrazole-3-carboxylic acid (3-{2-oxo-3-[(4-pyrrolidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1H-indole-6-carbonyl}-phenyl)-amide and polylactide |
| 08/20/2009 | US20090208554 Baclofen Formulation in a Polyorthoester Carrier |
| 08/20/2009 | US20090208552 Cross-linked fatty acid-based biomaterials |
| 08/20/2009 | US20090208550 Methods and compositions for treating hepatic diseases |
| 08/20/2009 | US20090208540 Implantable device for the delivery of naltrexone and methods of use thereof |
| 08/20/2009 | US20090208539 Stable atorvastatin formulations |
| 08/20/2009 | US20090208531 Antiviral agents and vaccines against influenza |
| 08/20/2009 | US20090208524 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 08/20/2009 | US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer |
| 08/20/2009 | US20090208514 Method of diagnosing esophageal cancer |
| 08/20/2009 | US20090208512 Catalytic anti-factor VIII allo-antibodies |
| 08/20/2009 | US20090208508 Novel use of ubiquitin c-terminal hydrolase-l1 |
| 08/20/2009 | US20090208507 Protein isoforms and uses thereof |
| 08/20/2009 | US20090208505 Mutations of the pik3ca gene in human cancers |
| 08/20/2009 | US20090208499 adminstering N-(phosphonomethyl)-proline free of N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine to a patient to treat cosmetic conditions and medical disorders, symptoms or syndromes associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system |
| 08/20/2009 | US20090208493 Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208484 R-spondin compositions and methods of use thereof |
| 08/20/2009 | US20090208483 Antibody selective for dr4 and uses thereof |
| 08/20/2009 | US20090208482 Human obesity susceptibility gene encoding a member of the neurexin family and uses thereof |
| 08/20/2009 | US20090208472 Oil-in-water emulsion composition containing licorice-derived polyphenol |
| 08/20/2009 | US20090208468 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| 08/20/2009 | US20090208462 Methods of Treatment |
| 08/20/2009 | US20090208457 Tricyclic-Nucleoside Prodrugs for Treating Viral Infections |
| 08/20/2009 | US20090208456 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| 08/20/2009 | US20090208449 Heterocyclic antiviral compounds |
| 08/20/2009 | US20090208448 Inhibition of angiogenesis |
| 08/20/2009 | US20090208446 DUB3 as a Cancer Therapy Target |
| 08/20/2009 | US20090208434 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use in cosmetic and pharmaceutical preparations |
| 08/20/2009 | US20090208433 AH Receptor Antagonists |
| 08/20/2009 | US20090208432 AH Receptor Antagonists |
| 08/20/2009 | US20090208427 Vanillin Acetals and Sensory Stimulant Composition Containing the Same |
| 08/20/2009 | US20090208426 Use of Diacetyl Trimer as an Aromatic and Flavouring Substance |
| 08/20/2009 | US20090208425 Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| 08/20/2009 | US20090208422 Composition for improving efficiency of drug delivery |
| 08/20/2009 | US20090208415 Tropane compounds |
| 08/20/2009 | DE112007001799T5 Liposomale Antioxidantien-Zusammensetzung zur Inhalation bei Erkrankungen der Lunge und der oberen Atemwege Antioxidants liposomal composition for inhalation in diseases of the lungs and upper respiratory tract |
| 08/20/2009 | DE10329874B4 Tajixanthonhydrat und dessen Verwendung zur Behandlung von Tumorerkrankungen Tajixanthonhydrat and its use for the treatment of tumor diseases |
| 08/20/2009 | DE102008010579A1 Combination product obtained from a base mixture as main components, useful for the treatment of atopic dermatitis, comprises synthetic glucocorticoid, sage extract and suitable base |
| 08/20/2009 | DE102008009929A1 3-(4-Hydroxy-3-methoxyphenyl)-1(4-hydroxphenyl)-1-propanon und deren Verwendung in kosmetischen und pharmazeutischen Zubereitungen 3- (4-hydroxy-3-methoxyphenyl) -1 (4-hydroxyphenyl) -1-propanone and their use in cosmetic and pharmaceutical preparations |
| 08/20/2009 | DE102008009797A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und Ethylhexyl-2-cyano-3,3-diphenylacrylat Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and ethylhexyl-2-cyano-3,3-diphenylacrylate |
| 08/20/2009 | DE102008009758A1 Verwendung von 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on zur verbesserten Hautkonturierung bzw. gegen Cellulite Using 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one for improved Hautkonturierung or cellulite |
| 08/20/2009 | DE102008009750A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und einem oder mehreren Polyolen Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and one or more polyols |
| 08/20/2009 | DE102008009749A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und einem oder mehreren Zimtsäurederivaten Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and one or more cinnamic acid derivatives |
| 08/20/2009 | DE102008009609A1 Substituierte 4-(Indol-3-yl)chinazoline und deren Verwendung und Herstellung Substituted 4- (indol-3-yl) quinazolines and their use and production |
| 08/20/2009 | DE102008008838A1 Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 08/20/2009 | DE102006007831B4 Vernetztes Kohlehydratpolymer, insbesondere auf Basis von Polysacchariden und/oder Oligosacchariden und/oder Polyolen Cross-linked carbohydrate polymer, in particular based on polysaccharides and / or oligosaccharides and / or polyols |
| 08/20/2009 | CA2723314A1 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | CA2720271A1 Compositions and methods for treating lung cancer |
| 08/20/2009 | CA2715839A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715815A1 Monomers and polymers with covalently-attached active ingredients |
| 08/20/2009 | CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715550A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715460A1 Continuous cell programming devices |
| 08/20/2009 | CA2715407A1 Method to predict response to pharmacological chaperone treatment of diseases |
| 08/20/2009 | CA2715400A1 Heterocyclic derivatives as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715373A1 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 08/20/2009 | CA2715367A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715326A1 Doxorubicin adjuvants to reduce toxicity and methods for using the same |
| 08/20/2009 | CA2715294A1 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/20/2009 | CA2715293A1 Selective agonist of toll-like receptor 3 |
| 08/20/2009 | CA2715289A1 Modified rnai polynucleotides and uses thereof |
| 08/20/2009 | CA2715282A1 Indole compounds and methods of use thereof |
| 08/20/2009 | CA2715261A1 Food products containing omega-3 fatty acids |
| 08/20/2009 | CA2715138A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | CA2714676A1 Treatments for neuropathy |
| 08/20/2009 | CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof |
| 08/20/2009 | CA2714598A1 Drug delivery system with stabilising effect |
| 08/20/2009 | CA2714591A1 Bicycloamine derivative |
| 08/20/2009 | CA2714580A1 Fluoroquinolone derivatives for ophthalmic applications |
| 08/20/2009 | CA2714542A1 Formulations of flibanserin |
| 08/20/2009 | CA2714532A1 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | CA2714530A1 Methods for the treatment and prevention of age-related retinal dysfunction |
| 08/20/2009 | CA2714524A1 Tablet having improved elution properties |
| 08/20/2009 | CA2714494A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 08/20/2009 | CA2714415A1 Fused pyridone m1 receptor positive allosteric modulators |
| 08/20/2009 | CA2714414A1 Certain substituted amides, method of making, and method of use thereof |
| 08/20/2009 | CA2714340A1 Estradiol-containing drug delivery system |
| 08/20/2009 | CA2714331A1 Selective opioid compounds |
| 08/20/2009 | CA2714301A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 08/20/2009 | CA2714254A1 Heterocyclic antiviral compounds |